Thomas Wilke

17PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyToxicology (incl. clinical toxicology)Predictive and prognostic markersMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 30, 2026
Association between proton pump inhibitor co-medication and treatment switching in dasatinib-treated patients with chronic myeloid leukemia: a German real-world evidence study.

|Aug 01, 2024
Switching within versus out of class following first-line TNFi failure in ulcerative colitis: real-world outcomes from a German claims data analysis.

Evi Zhuleku, Daniel Wirth, Riikka Nissinen

|Apr 22, 2024
Treatment patterns and clinical outcomes in metastatic urothelial carcinoma: a German retrospective real-world analysis.

Günter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock

|Apr 22, 2024
Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.

Kai-Michael Beeh, Kieran J Rothnie, Jing Claussen

|Apr 19, 2024
Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.

Günter Niegisch, Marc-Oliver Grimm, Fraence Hardtstock

|Nov 07, 2023
Association between treatment and improvements in overall survival of patients with advanced/metastatic non-small cell lung cancer since 2011: A study in the United States, Canada, and Germany using retrospective real-world databases.

Frank Griesinger, Sreeram Ramagopalan, Winson Y Cheung

Pageof 3

Frequent Collaborators

8 joint publications

Fränce Hardtstock

4 joint publications

Barthold Deiters

4 joint publications

Julia Krieger

2 joint publications

Marc-Oliver Grimm